Latest Advances

  • Condition: High-risk IgA Nephropathy
  • Journal: Medicine
  • Treatment Used: Immunosuppressive Therapies
  • Number of Patients: 3012
  • Published —
In this study, researchers evaluated the safety and effectiveness of immunosuppressive therapies for the treatment of high-risk IgA nephropathy.
  • Condition: Systemic Lupus Erythematosus
  • Journal: BioMed research international
  • Treatment Used: Mycophenolate Mofetil
  • Number of Patients: 119
  • Published —
In this study, researchers evaluated the safety and effectiveness of mycophenolate mofetil for the treatment of systemic lupus erythematosus in Japanese patients.
  • Condition: Acute Tracheal Necrosis after Intubation with Childhood Onset Systemic Lupus Erythematosus
  • Journal: Chest
  • Treatment Used: High-Dose Steroid Therapy
  • Number of Patients: 1
  • Published —
This case report describes a childhood onset systemic lupus erythematosus patient with acute tracheal necrosis that she developed after intubation.
  • Condition: Focal Segmental Glomerular Sclerosis (FSGS) Recurrence in Patient with Kidney Transplant
  • Journal: The American journal of case reports
  • Treatment Used: Cyclophosphamide
  • Number of Patients: 1
  • Published —
This case report describes a 24-year-old woman kidney transplant recipient diagnosed with primary focal segmental glomerular sclerosis (FSGS) treated with cyclophosphamide.
  • Condition: Ankylosing Spondylitis
  • Journal: BMJ case reports
  • Treatment Used: Infliximab
  • Number of Patients: 1
  • Published —
This case report describes a patient with ankylosing spondylitis.
  • Condition: Membranous Nepropathy
  • Journal: Journal of Nepal Health Research Council
  • Treatment Used: Rituximab
  • Number of Patients: 0
  • Published —
This article discusses the effectiveness of rituximab in the treatment of membranous nephropathy (autoimmune kidney disease).
  • Condition: Lupus Membranous Nephropathy
  • Journal: RMD open
  • Treatment Used: Filgotinib and Lanraplenib
  • Number of Patients: 9
  • Published —
In this study, researchers evaluated the safety and effectiveness of filgotinib and lanraplenib for the treatment of lupus membranous nephropathy.
  • Condition: Systemic Lupus Erythematosus with Chylothorax and/or Chylous Ascites
  • Journal: Medicine
  • Treatment Used: Glucocorticoids, Immunosuppressants, and Surgery
  • Number of Patients: 15
  • Published —
The study researched treatment for systemic lupus erythematosus with chylothorax and/or chylous ascites.
  • Condition: Membranous Nephropathy (MN)
  • Journal: Terapevticheskii arkhiv
  • Treatment Used: Cyclophosphane, Calcineurin Inhibitors, Rituximab, and Anti-CD20 Antibody Therapy
  • Number of Patients: 0
  • Published —
This article discusses newer treatments for patients with membranous nephropathy (kidney disease; MN).
Showing 1-12 of 181